SCHEMBL12731473

SCHEMBL12731473

c1ccc(-n2c3ccccc3c3c4ccc5ccc(-c6ccc(-c7cn8ccccc8n7)cc6)c6ccc(cc32)c4c56)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 13/20 0.43
▸ NPC1 O15118 12/20 0.43
▸ KDM4E B2RXH2 11/20 0.43
▸ ALDH1A1 P00352 8/20 0.43
▸ SMN1; SMN2 Q16637 8/20 0.43
▸ MAPT P10636 5/20 0.43
▸ HTT P42858 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ POLB P06746 2/20 0.42
▸ GFER P55789 3/20 0.41
▸ PKM P14618 5/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MIF P14174 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ MAPK1 P28482 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12731474 0.87 ALDH1A1 (0.49) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL12611731 0.85 RAB9A (0.44) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL2757069 0.82 RAB9A (0.57) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL15446944 0.81 RAB9A (0.44) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL12611958 0.80 KDM4E (0.44) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL14330569 0.79 ALDH1A1 (0.45) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL14330521 0.79 ALDH1A1 (0.47) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL4557225 0.79 RAB9A (0.56) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL14329634 0.78 RAB9A (0.44) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2
SCHEMBL2627515 0.78 RAB9A (0.47) RAB9ANPC1KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2308843-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND SAMSUNG DISPLAY CO LTD (KR) 2016-12-14 — — EP disclosed
US-9000420-B2 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-07 — — US disclosed
US-9000420-B2 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2015-04-07 — — US disclosed
US-20110084256-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-04-14 — — US disclosed
US-20110084256-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-04-14 — — US disclosed
EP-2308843-A1 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound Samsung Mobile Display Co., Ltd. (KR) 2011-04-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110084256-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE INCLUDING ORGANIC LAYER CONTAINING THE CONDENSED-CYCLIC COMPOUND CCNL2, C9, OCIAD1 RAB9A 2522/4885NPC1 611/4885KDM4E 3667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback